Concord Net Income Applicable To Common Shares from 2010 to 2026
| CCM Stock | USD 3.97 0.07 1.79% |
Net Loss | First Reported 2007-12-31 | Previous Quarter -45.5 M | Current Value -45.5 M | Quarterly Volatility 91.4 M |
Check Concord Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Concord Medical's main balance sheet or income statement drivers, such as Interest Expense of 233.3 M, Selling General Administrative of 488.3 M or Total Revenue of 417.7 M, as well as many indicators such as Price To Sales Ratio of 0.0163, Dividend Yield of 5.83 or Days Sales Outstanding of 53.14. Concord financial statements analysis is a perfect complement when working with Concord Medical Valuation or Volatility modules.
Concord | Net Income Applicable To Common Shares | Build AI portfolio with Concord Stock |
Evaluating Concord Medical's Net Income Applicable To Common Shares across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Concord Medical Services's fundamental strength.
Latest Concord Medical's Net Income Applicable To Common Shares Growth Pattern
Below is the plot of the Net Income Applicable To Common Shares of Concord Medical Services over the last few years. It is the net income that remains after preferred dividends have been deducted, available to common shareholders. Concord Medical's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Concord Medical's overall financial position and show how it may be relating to other accounts over time.
| Net Income Applicable To Common Shares | 10 Years Trend |
|
Net Income Applicable To Common Shares |
| Timeline |
Concord Net Income Applicable To Common Shares Regression Statistics
| Arithmetic Mean | (296,691,068) | |
| Geometric Mean | 108,179,954 | |
| Coefficient Of Variation | (88.17) | |
| Mean Deviation | 213,520,876 | |
| Median | (307,049,000) | |
| Standard Deviation | 261,599,596 | |
| Sample Variance | 68434.3T | |
| Range | 841.6M | |
| R-Value | (0.82) | |
| Mean Square Error | 24229.4T | |
| R-Squared | 0.67 | |
| Significance | 0.000062 | |
| Slope | (42,342,785) | |
| Total Sum of Squares | 1094949.6T |
Concord Net Income Applicable To Common Shares History
About Concord Medical Financial Statements
Concord Medical investors utilize fundamental indicators, such as Net Income Applicable To Common Shares, to predict how Concord Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Net Loss | -440.7 M | -418.7 M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out the analysis of Concord Medical Correlation against competitors. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Will Health Care Providers & Services sector continue expanding? Could Concord diversify its offerings? Factors like these will boost the valuation of Concord Medical. Projected growth potential of Concord fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Concord Medical data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (5.40) | Revenue Per Share | Quarterly Revenue Growth (0.08) | Return On Assets | Return On Equity |
Understanding Concord Medical Services requires distinguishing between market price and book value, where the latter reflects Concord's accounting equity. The concept of intrinsic value - what Concord Medical's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Concord Medical's price substantially above or below its fundamental value.
It's important to distinguish between Concord Medical's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Concord Medical should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Concord Medical's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.